v3.26.1
Condensed Consolidated Balance Sheet (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash, cash equivalents and current restricted cash $ 341,881 $ 369,074
Accounts receivable, net 79,636 90,255
Inventory, net 64,397 65,823
Other current assets and prepaid expenses 49,448 56,729
Total current assets 535,362 581,881
Property, plant and equipment, net 72,585 73,926
Intangible assets, net 496,351 516,276
In-process research and development 195,000 195,000
Goodwill 482,268 484,289
Investments 10,529 14,168
Operating lease right-of-use assets 45,800 46,930
Other assets 18,901 19,474
Total assets 1,856,796 1,931,944
Current liabilities:    
Accounts payable 44,176 41,103
Accrued expenses 83,476 84,406
Current maturities of operating leases 11,086 10,917
Current portion of lines of credit and notes payable 9,645 10,251
Total current liabilities 148,383 146,677
Operating lease liabilities 35,636 36,815
Long term portion of convertible notes 87,380 85,020
Senior secured royalty financing 246,643 246,433
Deferred tax liabilities 114,562 126,241
Other long-term liabilities 19,582 22,799
Total long-term liabilities 503,803 517,308
Total liabilities 652,186 663,985
Equity:    
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 784,892,433 and 789,917,433 shares issued at March 31, 2026 and December 31, 2025, respectively 7,850 7,900
Treasury Stock - 29,799,907, and 30,849,907 shares at March 31, 2026 and December 31, 2025, respectively (1,791) (3,176)
Additional paid-in capital 3,571,575 3,574,942
Accumulated other comprehensive loss (27,486) (21,017)
Accumulated deficit (2,345,538) (2,290,690)
Total shareholders’ equity 1,204,610 1,267,959
Total liabilities and equity $ 1,856,796 $ 1,931,944

Source

HTML PDF
ZIP